Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients

Supplemental Digital Content is available in the text. Volume status assessment in left ventricular assist device (LVAD) patients remains challenging. Cardiac resynchronization therapy (CRT) devices are common in LVAD patients, and the impedance across the CRT leads may be associated with hemodynamics and serve as a tool for noninvasive estimation of volume status. Ninety-one sets of measurements including cardiac filling pressures and lead impedances were prospectively obtained during ramp tests from 11 LVAD patients (65.5 ± 9.7 years old; nine male) with CRT devices. Right atrial (RA), right ventricular (RV), and left ventricular (LV) lead impedances were all significantly associated with central venous pressure (CVP) (p < 0.05). We derived the following equation: estimated CVP = 47.90–(0.086 × RA lead impedance) + (0.013 × RV lead impedance)–(0.020 × LV lead impedance). The estimated CVP had a significant correlation (r = 0.795) and good agreement with the measured CVP (mean difference –0.14 ± 1.77 mmHg). Applying the above equation on the validation cohort of twenty-one patients also maintained a strong association with measured CVP (r = 0.705). In conclusion, we have derived a novel equation to estimate CVP using lead impedance measurements. This finding may allow noninvasive monitoring of volume status in LVAD patients.

[1]  N. Narang,et al.  Highly Accurate Continuous Blood Pressure Measurement in LVAD Patients with a Non-Invasive, Non-Oscillometric Wearable Device: A Pilot Study , 2018 .

[2]  James W Long,et al.  Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[3]  Robert L Kormos,et al.  Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  D. Burkhoff,et al.  Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation , 2017, Circulation. Heart failure.

[5]  D. Burkhoff,et al.  HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump , 2017, ASAIO journal.

[6]  D. Rodgers,et al.  (1045) - The Accuracy of Physical Exam Compared to RHC in LVAD Patients , 2017 .

[7]  Valluvan Jeevanandam,et al.  Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.

[8]  D. Burkhoff,et al.  Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices. , 2016, JACC. Heart failure.

[9]  M. Loebe,et al.  Echocardiographic Evaluation of Hemodynamics in Patients With Systolic Heart Failure Supported by a Continuous-Flow LVAD. , 2014, Journal of the American College of Cardiology.

[10]  I. Komuro,et al.  Usefulness of transient elastography for noninvasive and reliable estimation of right-sided filling pressure in heart failure. , 2014, The American journal of cardiology.

[11]  Huai Luo,et al.  Noninvasive evaluation of right atrial pressure. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[13]  M. Santini,et al.  Intrathoracic and Ventricular Impedances are Associated with Changes in Ventricular Volume in Patients Receiving Defibrillators for CRT , 2010, Pacing and clinical electrophysiology : PACE.

[14]  Christian Butter,et al.  Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. , 2007, European heart journal.

[15]  Li Wang,et al.  Fundamentals of intrathoracic impedance monitoring in heart failure. , 2007, The American journal of cardiology.

[16]  C. Lau,et al.  Intrathoracic Impedance Monitoring in Patients With Heart Failure: Correlation With Fluid Status and Feasibility of Early Warning Preceding Hospitalization , 2005, Circulation.

[17]  M. Drazner,et al.  Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. , 2001, The New England journal of medicine.

[18]  B. Wilkoff,et al.  Correlation of Impedance Minute Ventilation with Measured Minute Ventilation in a Rate Responsive Pacemaker , 2001, Pacing and clinical electrophysiology : PACE.

[19]  G. Breithardt,et al.  Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow‐up of Implantable Cardioverter Defibrillators , 2001, Pacing and clinical electrophysiology : PACE.

[20]  M Schaldach,et al.  Closed‐Loop Stimulation Using Intracardiac Impedance as a Sensor Principle: Correlation of Right Ventricular dP/dtmax and Intracardiac Impedance During Dobutamine Stress Test , 2000, Pacing and clinical electrophysiology : PACE.

[21]  M. Allessie Atrial fibrillation-induced electrical remodeling in humans: what is the next step? , 1999, Cardiovascular research.

[22]  J. Afilalo,et al.  Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography , 2014 .

[23]  P. Schauerte,et al.  European InSync Sentry Observational Study Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure , 2007 .

[24]  M. Allessie,et al.  Structural changes of atrial myocardium during chronic atrial fibrillation. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.